课题基金 / 基金详情

The role of advanced glycaiton end products (AGEs) in the pathogenesis of age related macular degeneration and the development of a new modality of therapy

The role of advanced glycaiton end products (AGEs) in the pathogenesis of age related macular degeneration and the development of a new modality of therapy
晚期糖基化终产物(AGE)在年龄相关性黄斑变性发病机制中的作用和新治疗方式的开发
批准号:
12671711
负责人:
MURATA Toshinori
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

MURATA Toshinori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of the present study was to elucidate the mechanisms how the advanced glycation end products (AGEs) that deposited in soft drusen induce macrophage infiltration. We hypothesized that these macrophages induce choroidal neovasclarization. The following results were obtained in this study.1) AGEs induce an overexpression of monocyte chemoattractant protein-1 (MCP-1) in the cultured retinal pigment epithelial (RPE) cells.An overexpression of MCP-1 when stimulated by AGEs was detected by ELISA. In the surgical specimens, the RPE cells that had phagocytosed AGEs were positive for MCP-1 by immunohistochemistry. The adjacent macrophages were positive for tumor necrosis factor-1 (TNF- 1) and Inteleukin-1β (IL-1β). These cytokines then induced over-expression of vascular endothelial growth factor (VEGF) that has been reported to be the key angiogenic factor for choroidal neovasclarization.2) Sub-RPE cells deposition of AGEs induce macrophage infiltration into this space.AGEs were injected into the sub-retinal space of the rat eyes, which Induced a prominent macrophage Infiltration.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Murata T, Cui J, Taba KE, Oh JY, Spee C, Hinton DR, Ryan SJ.: "The possibility of gene therapy for the treatment of choroidal neovascularization"Ophthalmology. 107(7). 1364-73 (2000)
Murata T、Cui J、Taba KE、Oh JY、Spee C、Hinton DR、Ryan SJ.:“基因疗法治疗脉络膜新生血管的可能性”眼科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hangai M, Murata T, Miyawaki N, Spee C, LimJI, He S, Hinton DR, Ryan SJ.: "Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells"Invest Ophthalmol Vis Sci. 42(7). 1617-25 (2001)
Hangai M、Murata T、Miyawaki N、Spee C、LimJI、He S、Hinton DR、Ryan SJ.:“人视网膜色素上皮细胞中血管内皮生长因子对血管生成素-1 的上调”Invest Ophasemol Vis Sci。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Joussen AM, Murata T et al.: "Leukocyte-mediated endothelial cell injury and death in the diabetic retina"Am J Pathol. 158・1. 147-152 (2001)
Joussen AM、Murata T 等:“糖尿病视网膜中白细胞介导的内皮细胞损伤和死亡”Am J Pathol 158・1(2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    macular sensitivity changes depending on capillary dropout and macular edema
    • 批准号:
      20K09770
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      MURATA Toshinori
    • 依托单位:
    Treatment of diabetic macular edema by VEGF-SiRNA using ligand-inducible system
    • 批准号:
      26670752
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      MURATA Toshinori
    • 依托单位:
    Regeneration of retinal neuron using Muller cells in the infarction area
    • 批准号:
      24659759
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      MURATA Toshinori
    • 依托单位:
    Development of new treatment modality for daibetic macular edema using animal models
    • 批准号:
      23390400
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2011
    • 负责人:
      MURATA Toshinori
    • 依托单位:
    海外基金